The Impact of CRISPR-Cas System on Antiviral Therapy

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Vira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hadi Bayat, Fatemeh Naderi, Amjad Hayat Khan, Arash Memarnejadian, Azam Rahimpour
Format: Artigo
Sprache:Inglês
Veröffentlicht: Tabriz University of Medical Sciences 2018-11-01
Schriftenreihe:Advanced Pharmaceutical Bulletin
Schlagworte:
CRISPR-Cas
Antiviral therapy
Genome editing
Latent viruses
Delivery system
Online Zugang:https://apb.tbzmed.ac.ir/PDF/apb-19443
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge